BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 21440240)

  • 1. [Cost-benefit analysis of amniotic membrane transplantation for venous ulcers of the legs that are refractory to conventional treatment].
    Gutiérrez-Moreno S; Alsina-Gibert M; Sampietro-Colom L; Pedregosa-Fauste S; Ayala-Blanco P
    Actas Dermosifiliogr; 2011 May; 102(4):284-8. PubMed ID: 21440240
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cost analysis of negative-pressure wound therapy with instillation for wound bed preparation preceding split-thickness skin grafts for massive (>100 cm(2)) chronic venous leg ulcers.
    Yang CK; Alcantara S; Goss S; Lantis JC
    J Vasc Surg; 2015 Apr; 61(4):995-9. PubMed ID: 25595397
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Amniotic membrane transplantation in the treatment of chronic lower limb ulcers.
    Alsina-Gibert M; Pedregosa-Fauste S
    Actas Dermosifiliogr; 2012 Sep; 103(7):608-13. PubMed ID: 22578292
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of amniotic membrane transplantation in the treatment of venous leg ulcers.
    Mermet I; Pottier N; Sainthillier JM; Malugani C; Cairey-Remonnay S; Maddens S; Riethmuller D; Tiberghien P; Humbert P; Aubin F
    Wound Repair Regen; 2007; 15(4):459-64. PubMed ID: 17650088
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cost-effectiveness of wound management in France: pressure ulcers and venous leg ulcers.
    Meaume S; Gemmen E
    J Wound Care; 2002 Jun; 11(6):219-24. PubMed ID: 12096580
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cost-effectiveness of three adjunct cellular/tissue-derived products used in the management of chronic venous leg ulcers.
    Carter MJ; Waycaster C; Schaum K; Gilligan AM
    Value Health; 2014 Dec; 17(8):801-13. PubMed ID: 25498775
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Up-to-date role of the dehydrated human amnion/chorion membrane (AMNIOFIX) for wound healing.
    Joshi CJ; Hassan A; Carabano M; Galiano RD
    Expert Opin Biol Ther; 2020 Oct; 20(10):1125-1131. PubMed ID: 32580594
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Wound care in venous ulcers.
    Mosti G
    Phlebology; 2013 Mar; 28 Suppl 1():79-85. PubMed ID: 23482540
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Amniotic membrane graft in ocular surface disease. Prospective study with 31 cases].
    Muraine M; Descargues G; Franck O; Villeroy F; Toubeau D; Menguy E; Martin J; Brasseur G
    J Fr Ophtalmol; 2001 Oct; 24(8):798-812. PubMed ID: 11894530
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The possible use of amniotic membrane in chronic leg ulcers.
    Somerville PG
    Phlebologie; 1982; 35(1):223-9. PubMed ID: 7071173
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vivo analysis of stromal integration of multilayer amniotic membrane transplantation in corneal ulcers.
    Nubile M; Dua HS; Lanzini M; Ciancaglini M; Calienno R; Said DG; Pocobelli A; Mastropasqua R; Carpineto P
    Am J Ophthalmol; 2011 May; 151(5):809-822.e1. PubMed ID: 21310388
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cultured corneal epithelia for ocular surface disease.
    Schwab IR
    Trans Am Ophthalmol Soc; 1999; 97():891-986. PubMed ID: 10703147
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of Amniotic Membrane as a Biological Dressing for the Treatment of Torpid Venous Ulcers: A Case Report.
    Alonso-Carpio M; Sánchez-García A; Trapero A; Pérez-Del Caz MD
    Plast Surg Nurs; 2020; 40(3):135-137. PubMed ID: 32852439
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Human amniotic membrane in the management of chronic venous leg ulcers].
    Tauzin H; Humbert P; Viennet C; Saas P; Muret P
    Ann Dermatol Venereol; 2011; 138(8-9):572-9. PubMed ID: 21893230
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The role of a radical surgical debridement and mesh graft tissue transfer for treatment of venous ulcers].
    Beckert S; Coerper S; Becker HD
    Zentralbl Chir; 2003 Aug; 128(8):680-4. PubMed ID: 12931265
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of bioengineered skin substitutes on diabetic foot ulcer and venous leg ulcer outcomes.
    Barber C; Watt A; Pham C; Humphreys K; Penington A; Mutimer K; Edwards M; Maddern G
    J Wound Care; 2008 Dec; 17(12):517-27. PubMed ID: 19052516
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Health economics for treatment of diabetic foot ulcers: a cost-effectiveness analysis of eight skin substitutes.
    Samsell B; McLean J; Cazzell S; Dorsch K; Moyer PM; Moore M
    J Wound Care; 2019 Sep; 28(Sup9):S14-S26. PubMed ID: 31509489
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is there an easier way to autograft skin in chronic leg ulcers? 'Minced micrografts', a new technique.
    Boggio P; Tiberio R; Gattoni M; Colombo E; Leigheb G
    J Eur Acad Dermatol Venereol; 2008 Nov; 22(10):1168-72. PubMed ID: 18410335
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Ambulatory skin grafting in leg ulcers: a feasibility study of 34 patients].
    Carrotte-Lefebvre I; Laussel AC; Catteau B; Thomas P
    Ann Dermatol Venereol; 2000 Jan; 127(1):46-50. PubMed ID: 10717562
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Amniotic Membrane Adjuncts and Clinical Applications in Wound Healing: A Review of the Literature.
    Kogan S; Sood A; Granick MS
    Wounds; 2018 Jun; 30(6):168-173. PubMed ID: 30059334
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.